The effect of one-year cross-sex hormonal treatment on bone metabolism and serum insulin-like growth factor-1 in transsexuals

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 6, 1996, Pages 2227-2232

  Van Kesteren, P ^a   Lips, P ^a   Deville, W ^a   Popp snijders, C ^a   Asscheman, H ^a   Megens, J ^a   Gooren, L ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; CYPROTERONE ACETATE; ESTRADIOL; ETHINYLESTRADIOL; TESTOSTERONE;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE MINERAL; BONE TURNOVER; FEMALE; HORMONAL THERAPY; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TRANSDERMAL DRUG ADMINISTRATION; TRANSSEXUALISM;

ADOLESCENT; ADULT; AGED; ALKALINE PHOSPHATASE; ANDROGEN ANTAGONISTS; ANDROGENS; BONE AND BONES; BONE DENSITY; ESTROGENS; FEMALE; GONADAL STEROID HORMONES; HORMONES; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; TRANSSEXUALISM;

EID: 0029948018     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.6.2227     Document Type: Article

References (36)

1. Turner RT, Riggs BL, Speisberg TC. 1994 Skeletal effects of estrogen. Endocr Rev. 15:275-300.
2. Orwoll ES, Klein RF. 1995 Osteoporosis in men. Endocr Rev. 16:87-116.
3. Shore RM, Chesney RW, Mazess RB, Rose PG, Bargman GJ. 1982 Skeletal demineralization in Turner's syndrome. Calcif Tissue Int. 34:519-522.
4. Genant HK, Cann CE, Ettinger B, Gordan GS. 1982 Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med. 97:699-705.
5. Drinkwater BL, Nilson K, Chesnut CH, Bremner WJ, Shainholtz S, Southworth MB. 1984 Bone mineral content of amenorrheic and eumenorrheic athletes. N Engl J Med. 311:277-281.
6. Greenspan SL, Neer RM, Ridgway EC, Klibanski A. 1986 Osteoporosis in men with hyperprolactinemic hypogonadism. Ann Intern Med. 104:777-782.
7. Finkelstein JS, Klibanski A, Neer RM, Greenspan SL, Rosenthal DI, Crowley WFJ. 1987 Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med. 106:354-361.
8. Stepan JJ, Lachman M, Zverina J, Pacovsky V, Baylink DJ. 1989 Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab. 69:523-527.
9. Francis RM, Peacock M, Aaron JE, et al. 1986 Osteoporosis in hypogonadal men: role of decreased plasma 1,25-dihydroxyvitamin D, calcium malabsorption, and low bone formation. Bone. 7:261-268.
10. Jackson JA, Kleerekoper M, Parfitt AM, Rao DS, Villanueva AR, Frame B. 1987 Bone histomorphometry in hypogonadal and eugonadal men with spinal Osteoporosis. J Clin Endocrinol Metab. 65:53-58.
11. Murphy S, Khaw KT, Cassidy A, Compston JE. 1993 Sex hormones and bone mineral density in elderly men. Bone Miner. 20:133-140.
12. Aitken JM, Hart DM, Lindsay R. 1995 Estrogen replacement therapy for prevention of Osteoporosis after oophorectomy. Br Med J. 3:515-518.
13. Recker RR, Saville PD, Heaney RP. 1977 Effect of estrogens and calcium carbonate on bone loss in postmenopausal women. Ann Intern Med. 87:649-655.
14. Felson DT, Zhang Y, Hannan MT, Kiel DP, Wilson PW, Anderson JJ. 1993 The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med. 329:1141-1146.
15. Gulekli B, Davies MC, Jacobs HS. 1994 Effect of treatment on established Osteoporosis in young women with amenorrhoea. Clin Endocrinol (Oxf). 41: 275-281.
16. Finkelstein JS, Klibanski A, Neer RM, et al. 1989 Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 69:776-783.
17. Diamond T, Stiel D, Posen S. 1991 Effects of testosterone and venesection on spinal and peripheral bone mineral in six hypogonadal men with hemochromatosis. J Bone Miner Res. 6:39-43.
18. Canalis E. 1994 Skeletal growth factors and aging. J Clin Endocrinol Metab. 78:1009-1010.
19. Nicolas V, Prewett A, Bettica P, et al. 1994 Age-related decreases in insulin-like growth factor-I and transforming growth factor-beta in femoral cortical bone from both men and women: implications for bone loss with aging. J Clin Endocrinol Metab. 78:1011-1016.
20. Hobbs CJ, Plymate SR, Rosen CJ, Adler RA. 1993 Testosterone administration increases insulin-like growth factor-I levels in normal men. J Clin Endocrinol Metab. 77:776-779.
21. Weissberger AJ, Ho KK, Lazarus L. 1991 Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab. 72:374-381.
22. Ho KK, Weissberger AJ. 1992 Impact of short-term estrogen administration on growth hormone secretion and action: distinct route-dependent effects on connective and bone tissue metabolism. J Bone Miner Res. 7:821-827.
23. Walton RJ, Bijvoet OL. 1975 Nomogram for derivation of renal threshold phosphate concentration. Lancet. 2:309-310.
24. Teerlink T, Tavenier P, Netelenbos JC. 1989 Selective determination of hydroxyproline in urine by high-performance liquid chromatography using precolumn derivatization. Clin Chim Acta. 183:309-315.
25. Christiansen C, Christensen MS, Larsen NE, Transbol IB. 1982 Pathophysiological mechanisms of estrogen effect on bone metabolism. Dose-response relationships in early postmenopausal women. J Clin Endocrinol Metab. 55: 1124-1130.
26. Lips P, Asscheman H, Uitewaal P, Netelenbos JC, Gooren L. 1989 The effect of cross-gender hormonal treatment on bone metabolism in male-to-female transsexuals. J Bone Miner Res. 4:657-662.
27. Eriksen EF, Steiniche T, Meisen F. 1993 Estrogen and bone remodeling. In: Christiansen C, Riis BJ, eds. Proceedings 1993. Aalborg: Handelstrykkeriet Aalborg; 399-401.
28. Smith EP, Boyd J, Frank GR, et al. 1994 Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med. 331:1056-1061.
29. Kanis JA, Beneton MNC, Gennari C, et al. 1993 Effects of anabolic steroids on cortical bone and fractures. In: Christiansen C, Riis BJ, eds. Proceedings 1993. Aalborg: Handelstrykkeriet Aalborg; 308-310.
30. Falch JA, Gautvik KM. 1988 A longitudinal study of pre- and postmenopausal changes in calcium metabolism. Bone. 9:15-19.
31. Stepan JJ, Pospichal J, Schreiber V, et al. 1989 The application of plasma tartrate-resistant acid phosphatase to assess changes in bone resorption in response to artificial menopause and its treatment with estrogen or norethisterone. Calcif Tissue Int. 45:273-280.
32. Stege R, Frohlander N, Carlstrom K, Pousette A, von Schoultz B. 1987 Steroid-sensitive proteins, growth hormone and somatomedin C in prostatic cancer: effects of parenteral and oral estrogen therapy. Prostate. 10:333-338.
33. Caufriez A, Golstein J, Tadjerouni A, et al. 1986 Modulation of immunoreactive somatomedin-C levels by sex steroids. Acta Endocrinol (Copenh). 112: 284-289.
34. Meyer WJ, Furlanetto RW, Walker PA. 1982 The effect of sex steroids on radioimmunoassayable plasma somatomedin C concentrations. J Clin Endocrinol Metab. 55:1184-1187.
35. Liu L, Merriam GR, Sherins RJ. 1987 Chronic sex steroid exposure increases mean plasma growth hormone concentration and pulse amplitude in men with isolated hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 64:651-656.
36. Azziz R, Deal CL, Potter HD, Gargosky SE, Rosenfeld RG. 1994 Regulation of extragonadal insulin-like growth factor-binding protein-3 by testosterone in oophorectomized women. J Clin Endocrinol Metab. 79:1747-1751.